Description: Hikal Limited, together with its subsidiaries, manufactures and sells various chemical intermediates, specialty chemicals, and active pharma ingredients to pharmaceutical, animal health, biotech, crop protection, and specialty chemicals companies in India, the United States, Canada, Europe, South East Asia, and internationally. It operates through two segments, Pharmaceuticals and Crop Protection. The Pharmaceuticals segment produces active pharmaceutical ingredients (APIs). Its Crop Protection segment manufactures pesticides and herbicides, which include diuron tech, temephos tech, thiacloprid tech, clothianidin tech, dichloroaniline, N-bromosuccinimide, prothioconazole technical, trifloxystrobin technical, and BIT. The company also collaborates with other companies; and offers solutions in contract research, custom synthesis, and custom manufacturing of intermediates and active ingredients. In addition, it offers human health products, such as anti-convulsant, anti-emetic, anti-histaminic, anti-depressant, anti-psychotic, anti-lipemic, hemorheologic, anti-diabetic, anti-thrombotic, anti-hypertensive, anti-inflammation, and analgesic; animal health products, such as anti-tick, anti-parasitic, analgesic, anabolic steroids, female sex hormone, and NSAID; and specialty biocides and antimicrobial actives, as well as additives for leather, paint coatings, paper, water treatment, personal care, building materials, and textile industries. The company also exports its products. The company was formerly known as Hikal Chemical Industries Ltd. and changed its name to Hikal Limited in April 2000. Hikal Limited was incorporated in 1988 and is headquartered in Navi Mumbai, India.
Home Page: www.hikal.com
Great Eastern Chambers
Navi Mumbai,
400614
India
Phone:
91 22 6277 0299
Officers
| Name | Title |
|---|---|
| Mr. Jai Vishwanath Hiremath | Founder & Executive Chairman |
| Mr. Sameer Jai Hiremath | MD & Executive Director |
| Mr. Rajasekhar Reddy Chintakindi | Company Secretary & Compliance Officer |
| Mr. Anish Dilip Swadi | Senior President of Animal Health & Business Transformation |
| Mr. Kuldeep Jain | Chief Financial Officer |
| Mr. Dharmesh Panchal | Chief Technology Officer |
| Mr. Ratish Jha | President of Human Resources |
| Mr. Manoj Mehrotra | President of Pharmaceuticals Business |
| Dr. T. Devanathan | Head of IP & Quality, Pharmaceuticals |
| Mr. Vimal Deep Kulshrestha | President of Crop Protection |
Exchange: NSE
Country: IN : India
Currency: Indian Rupee (INR)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Pharmaceuticals, Biotechnology & Life Sciences |
| GIC Industry: | Pharmaceuticals |
| GIC Sub-Industry: | Pharmaceuticals |
| Forward PE: | 16.7504 |
|---|---|
| Trailing PE: | 73.4732 |
| Price-to-Book MRQ: | 4.4867 |
| Price-to-Sales TTM: | 2.981 |
| IPO Date: | |
| Fiscal Year End: | March |
| Full Time Employees: | 2061 |